100 related articles for article (PubMed ID: 1812593)
61. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing.
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Cancer; 1990 Sep; 66(5):930-5. PubMed ID: 2167148
[TBL] [Abstract][Full Text] [Related]
62. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
[TBL] [Abstract][Full Text] [Related]
63. Comparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing.
Zhang H; Zheng X; Ji T; Fu L; Bai D; Liao Y; Zhang H; Ding Y; Zheng L
Cell Biochem Biophys; 2012 Apr; 62(3):415-20. PubMed ID: 22048888
[TBL] [Abstract][Full Text] [Related]
64. Ras mutations in United Kingdom examples of oral malignancies are infrequent.
Chang SE; Bhatia P; Johnson NW; Morgan PR; McCormick F; Young B; Hiorns L
Int J Cancer; 1991 May; 48(3):409-12. PubMed ID: 2040536
[TBL] [Abstract][Full Text] [Related]
65. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
66. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
67. Expression and mutation of H-ras in uterine cervical cancer.
Lee JH; Lee SK; Yang MH; Ahmed MM; Mohiuddin M; Lee EY
Gynecol Oncol; 1996 Jul; 62(1):49-54. PubMed ID: 8690291
[TBL] [Abstract][Full Text] [Related]
68. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
69. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
70. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.
Chen CY; Shiesh SC; Wu SJ
Clin Chem; 2004 Mar; 50(3):481-9. PubMed ID: 14718395
[TBL] [Abstract][Full Text] [Related]
71. High incidence of point mutation in K-ras codon 12 in carcinoma of the fallopian tube.
Mizuuchi H; Mori Y; Sato K; Kamiya H; Okamura N; Nasim S; Garrett CT; Kudo R
Cancer; 1995 Jul; 76(1):86-90. PubMed ID: 8630881
[TBL] [Abstract][Full Text] [Related]
72. Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases.
Lee KH; Lee JS; Suh C; Kim SW; Kim SB; Lee JH; Lee MS; Park MY; Sun HS; Kim SH
Cancer; 1995 Jun; 75(12):2794-801. PubMed ID: 7773929
[TBL] [Abstract][Full Text] [Related]
73. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.
Ward R; Hawkins N; O'Grady R; Sheehan C; O'Connor T; Impey H; Roberts N; Fuery C; Todd A
Am J Pathol; 1998 Aug; 153(2):373-9. PubMed ID: 9708798
[TBL] [Abstract][Full Text] [Related]
74. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
[TBL] [Abstract][Full Text] [Related]
75. Detection of K-ras mutations in cancerous lesions of human endometrium.
Semczuk A; Berbéc H; Kostuch M; Kotarski J; Wojcierowski J
Eur J Gynaecol Oncol; 1997; 18(1):80-3. PubMed ID: 9061333
[TBL] [Abstract][Full Text] [Related]
76. Unique K-ras mutational pattern in pancreatic adenocarcinoma from Taiwanese patients.
Wang JY; Lian ST; Chen YF; Yang YC; Chen LT; Lee KT; Huang TJ; Lin SR
Cancer Lett; 2002 Jun; 180(2):153-8. PubMed ID: 12175546
[TBL] [Abstract][Full Text] [Related]
77. Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: lack of correlation with established prognostic factors.
Semczuk A; Stenzel A; Baranowski W; Rózynska K; Cybulski M; Kostuch M; Jakowicki J; Wojcierowski J
Oncol Rep; 2000; 7(4):905-10. PubMed ID: 10854568
[TBL] [Abstract][Full Text] [Related]
78. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma.
Motojima K; Urano T; Nagata Y; Shiku H; Tsurifune T; Kanematsu T
Ann Surg; 1993 Feb; 217(2):138-43. PubMed ID: 8439212
[TBL] [Abstract][Full Text] [Related]
79. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
80. Comparison of ras activation in prostate carcinoma in Japanese and American men.
Konishi N; Hiasa Y; Tsuzuki T; Tao M; Enomoto T; Miller GJ
Prostate; 1997 Jan; 30(1):53-7. PubMed ID: 9018336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
